Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
SGEN > SEC Filings for SGEN > Form 8-K on 2-Nov-2012All Recent SEC Filings

Show all filings for SEATTLE GENETICS INC /WA



Change in Directors or Principal Officers

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On October 30, 2012, Thomas C. Reynolds, M.D., Ph.D., Chief Medical Officer of Seattle Genetics, Inc. ("Seattle Genetics" or "the Company"), informed the Company of his resignation in connection with his retirement for a family health matter. Dr. Reynolds will continue to serve as the Company's Chief Medical Officer until December 31, 2012. Dr. Reynolds has been a key contributor at Seattle Genetics, notably through his leadership of the Company's clinical and regulatory teams during the development and approval of ADCETRIS®. The Company has started a search for a replacement to Dr. Reynolds and anticipates a seamless transition of responsibilities over the next several months.

  Add SGEN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for SGEN - All Recent SEC Filings
Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.